DRKS00027497
Not yet recruiting
Not Applicable
Pharmacy-based interdisciplinary screening for hypertension - PHARM-HT
ABDA - Bundesvereinigung Deutscher Apothekerverbände e. V.0 sites100 target enrollmentJanuary 18, 2022
ConditionsHypertention
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hypertention
- Sponsor
- ABDA - Bundesvereinigung Deutscher Apothekerverbände e. V.
- Enrollment
- 100
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Informed consent
Exclusion Criteria
- •Diagnosis of hypertention, taking antihypertensive drugs (blood pressure lowering agents ATC codes C03, C07, C08, C09 incl. C04, C02 (including clonidine, moxonidine, doxazosin), C01 (nitrates)) or G04 (alpha\-blockers), coffee, energy drinks or black tea up to 30 minutes before blood pressure measurement
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Pharmacy based screening of high risk individuals using stepwise methodsEarly detection of type 2 diabetesNutritional, Metabolic, EndocrineNon-insulin-dependent diabetes mellitusISRCTN10605140niversity of Leicester (UK)2,406
Completed
Not Applicable
Pharmacy pilot to detect hypertension and atrial fibrillatioHypertension and atrial fibrillationCirculatory SystemISRCTN26825087Irish Pharmacy Union1,000
Completed
Not Applicable
Examining a unique medication for alcoholic smokersISRCTN62137064ABMRF/The Foundation for Alcohol Research (USA)30
Completed
Not Applicable
Clinical application of drug screening in circulating tumor cells in patients with breast cancersClinical application of drug screening in circulating tumor cells in patients with breast cancersCancerISRCTN10116660inkou Chang Gung Memorial Hospital34
Not yet recruiting
Phase 3
Verifying the rubrics Food and Drinks in Synthesis RepertoryCTRI/2024/02/063332I